You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 262 No. 2, July 14, 1989 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Brief Reports
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (46)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Spread of Chloroquine-Resistant Malaria in Africa

Implications for Travelers

John S. Moran, MD; Kenneth W. Bernard, MD, DTM&H

JAMA. 1989;262(2):245-248.


Abstract

Spreading from 2 countries in 1978 to at least 29 in 1988, chloroquine-resistant Plasmodium falciparum malaria has become a significant concern for travelers to Africa. The spread of chloroquine resistance has been documented by sporadic case reports and by isolated population surveys, which do not always completely reflect the risk of infection for travelers using chloroquine prophylaxis. Surveillance of Peace Corps volunteers in West Africa indicates that as of January 1, 1989, P falciparum malaria resistant to chloroquine prophylaxis had spread as far west as Liberia, with only limited risk in Sierra Leone and to the north and west of Sierra Leone. Monitoring the incidence of malaria in highly exposed expatriates provides early warning of the emergence of drug-resistant P falciparum malaria and can provide data to guide recommendations for travelers.

(JAMA. 1989;262:245-248)



Author Affiliations

From the Office of Medical Services, Peace Corps, Washington, DC (Dr Moran); and the International Health Programs Office, Centers for Disease Control, Atlanta, Ga (Dr Bernard). Dr Moran is now with the Division of Sexually Transmitted Diseases, Center for Prevention Services, Centers for Disease Control, Atlanta.


Footnotes

Reprints not available.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Development through civic service: the Peace Corps and national service programmes in Ghana
Frontani and Taylor
Progress in Development Studies 2009;9:87-99.
ABSTRACT  

trans Expression of a Plasmodium falciparum Histidine-rich Protein II (HRPII) Reveals Sorting of Soluble Proteins in the Periphery of the Host Erythrocyte and Disrupts Transport to the Malarial Food Vacuole
Akompong et al.
J. Biol. Chem. 2002;277:28923-28933.
ABSTRACT | FULL TEXT  

The In Vitro Hepatic Metabolism of Quinine in Mice, Rats and Dogs: Comparison with Human Liver Microsomes
Zhao and Ishizaki
J. Pharmacol. Exp. Ther. 1997;283:1168-1176.
ABSTRACT | FULL TEXT  

Malaria Chemoprophylaxis for the Traveler
Wyler
NEJM 1993;329:31-37.
FULL TEXT  

Effectiveness and Tolerance of Long-term Malaria Prophylaxis With Mefloquine: Need for a Better Dosing Regimen
Lobel et al.
JAMA 1991;265:361-364.
ABSTRACT  

Imported Plasmodium falciparum Malaria in American Travelers to Africa: Implications for Prevention Strategies
Lackritz et al.
JAMA 1991;265:383-385.
ABSTRACT  

Prevention of Malaria
Hoffman
JAMA 1991;265:398-399.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.